Austrian guidelines for prophylaxis of venous thromboembolism;Leitlinien für die venöse thromboembolieprophylaxe in Österreich

Wiener Klinische Wochenschrift

Volumn 119, Issue 23-24, 2007, Pages 739-746

  Pabinger, Ingrid ^a   Eichinger, Sabine ^a   Minar, Erich ^a   Niessner, Herwig ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Krankenhaus Wiener Neustadt   (Austria)

Author keywords

Deep vein thrombosis; Guidelines; Pulmonary embolism; Thrombosis prophylaxis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; CERTOPARIN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

DEEP VEIN THROMBOSIS; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; LUNG EMBOLISM; PRACTICE GUIDELINE; REVIEW; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 37749001979     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0915-z     Document Type: Review

References (15)

1. Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlebologie (2006) Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 25 (2): 101-161
2. Cohen AT, Davidson BL, Gallus AS, et al (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients. Randomized placebo controlled trial (ARTEMIS). BMJ 332: 325-329
3. Cohen AT, et al (2007) A large-scale, global observational study of venous thromboembolism risk and prophylaxis in the acute hospital care setting: the ENDORSE study. XXIst Conference of the ISTH, July, Geneva, abstr 0-S-002
4. Colwell CW Jr, Kwong LM, Turpie AG, Davidson BL (2006) Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery (FLEXTRA Study). J Arthroplasty 21: 36-45
5. Eriksson BI, Lassen MR, PENTHIFRA Plus Study: For the Pentasaccharide in Hip-fracture Surgery Plus (PENTHIFRA Plus) Investigators (2003) Duration of prophylaxis against venous thromboembolism fondaparinux after Hip-fracture Surgery: A multi-center, randomized, placebo-controlled, double blind study. Arch Intern Med 163: 1337-1342
6. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, Sep 126: 338S-400S
7. Geerts WH (2007) Personal communication
8. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Zelman Lewis S, Schünemann H (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest 129: 174-181
9. Ritschl P, Hochreiter J, Kotz R, Krismer M, Niessner H, Schwarz B, Windhager R; unter Patronanz der Österreichischen Gesellschaft für Orthopädie und Orthopädische Chirurgie (2007) Thromboseprophylaxe in der orthopädischen Chirurgie. Österreichische Ärztezeitung [Suppl]: 1-8
10. Hull RD, et al (2007) Extended-duration venous thromboembolism (VTE) prophylaxis in acutely ill medical patients with recent reduced mobility: the EXCLAIM study. XXIst Conference of the ISTH, Geneva, abstr. 0-S-001
11. Leizorovic A, Cohen AT, Turpie AG, et al (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients (PREVENT). Circulation 110: 8749
12. Lindblad B, Sternby NH, Bergqvist D (1991) Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 302: 709-711
13. Nelzén O, Bergqvist D, Lindhagen A, Hallböök T (1991) Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. J Epidemiol Community Health 45: 184-187
14. Nordström M, Lindblad B, Bergqvist D, Kjellström T (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232: 155-160
15. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery. A metaanalysis of 4 randomized double blind studies. Arch Intern Med 162: 1833-1840